» Articles » PMID: 25587302

Evaluation of Lipid-based Drug Delivery System (Phytosolve) on Oral Bioavailability of Dibudipine

Overview
Publisher Brieflands
Specialty Pharmacology
Date 2015 Jan 15
PMID 25587302
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of present study was to evaluate pharmacokinetic parameters of dibudipine Phytosolve after oral administration in rats. The solubility test was carried out to select suitable oily solvent for dibudipine. Phytosolve formulation was prepared with a medium chain triglyceride (MCT) oil (20%), soybean phospholipids (5%) and a 70% fructose solution (75%). The effect of polyol content on the mean globule size of Phytosolve formulation was studied. The optimized formulation was evaluated for robustness toward dilution, transparency, droplet size, zeta potential and transmission electron microscopic analysis. The Phytosolve of dibudipine with an average droplet size of 142.3 ± 4.3 nm and surface charge -18.36 ± 0.37 mv was administered orally to rats. The average relative bioavalabilities of dibudipine in the plasma with Phytosolve were 170.4% and 211.2% as compared to the oily solution and aqueous suspension respectively. So this formulation could be offered as a useful technique to improve the oral delivery of the poorly water soluble drugs such as dibudipine.

Citing Articles

Lipids Fortified Nano Phytopharmaceuticals: A Breakthrough Approach in Delivering Bio-actives for Improved Therapeutic Efficacy.

Shah S, Chauhan H, Madhu H, Mori D, Soniwala M, Singh S Pharm Nanotechnol. 2024; 13(1):70-89.

PMID: 38279712 DOI: 10.2174/0122117385277686231127050723.


The Effect of Vitamin D3 Supplemented with PhytoSolve on Genes Involved in Implantation in an NMRI Mice Model of Polycystic Ovary Syndrome: An Experimental Study.

Hakimpour S, Govahi A, Eghbali S, Shabani R, Mehdizadeh R, Ajdary M JBRA Assist Reprod. 2023; .

PMID: 37962973 PMC: 10718550. DOI: 10.5935/1518-0557.20230064.


Effects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial.

Sayyah M, Boostani H, Ashrafpoori M, Pakseresht S Iran J Pharm Res. 2015; 14(4):1269-74.

PMID: 26664396 PMC: 4673957.

References
1.
Hadian Z, Sahari M, Moghimi H, Barzegar M . Formulation, characterization and optimization of liposomes containing eicosapentaenoic and docosahexaenoic acids; a methodology approach. Iran J Pharm Res. 2014; 13(2):393-404. PMC: 4157015. View

2.
Bohlooli S, Keyhanfar F, Ghiaee S, Mahmoudian M . Application of a new high performance liquid chromatography method to the pharmacokinetics of dibudipine in rats. J Pharm Pharm Sci. 2004; 6(3):346-51. View

3.
Mirkhani H, Omrani G, Ghiaee S, Mahmoudian M . Effects of mebudipine and dibudipine, two new calcium-channel blockers, on rat left atrium, rat blood pressure and human internal mammary artery. J Pharm Pharmacol. 1999; 51(5):617-22. DOI: 10.1211/0022357991772727. View

4.
Gannu R, Palem C, Yamsani V, Yamsani S, Rao Yamsani M . Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterization. Int J Pharm. 2010; 388(1-2):231-41. DOI: 10.1016/j.ijpharm.2009.12.050. View

5.
Gershanik T, Benita S . Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000; 50(1):179-88. DOI: 10.1016/s0939-6411(00)00089-8. View